Spectrum and Antibiotic Sensitivity Pattern of Bloodstream Bacterial Isolates from Septicemic Neonates in a Tertiary Care Centre
International Journal of Current Pharmaceutical Review and Research · 11.05.2026 · 18 (04)
DOI: 10.25258/ijcpr.18.4.109 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 11.05.2026. Verfasst von Ganesh Kumar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Neonatal septicemia continues to contribute substantially to NICU morbidity and mortality, and the changing pathogen spectrum together with rising antimicrobial resistance makes local antibiograms essential for rational empirical therapy.
Aim
To determine the spectrum of bloodstream bacterial isolates from septicemic neonates in a tertiary care centre and to define their antibiotic sensitivity pattern with attention to onset-specific distribution and multidrug resistance.
Methods
This submission-style original article draft was structured as a Jawaharlal Nehru Medical College & Hospital, Bhagalpur-based observational study over 18 months from 15th January 2025 to 30th December 2025 in a tertiary care neonatal unit. A total of 214 neonates with clinically suspected septicemia were evaluated; 68 blood cultures yielded clinically significant bacterial growth. Early-onset sepsis was defined as onset within 72 hours of life and late-onset sepsis as onset after 72 hours. Blood cultures were processed using standard microbiological techniques, bacterial identification was performed by conventional/automated methods, and antimicrobial susceptibility testing was interpreted according to current CLSI criteria. Categorical variables were compared using chi-square or Fisher exact testing, and odds ratios with 95% confidence intervals were calculated for selected predictors.
Results
Overall blood culture positivity was 31.8% (68/214). Culture positivity was significantly associated with prematurity (OR 2.15, 95% CI 1.18-3.93; p=0.013), low birth weight (OR 2.15, 95% CI 1.14-4.08; p=0.022), outborn status (OR 1.92, 95% CI 1.07-3.43; p=0.037), prior invasive ventilation (OR 2.77, 95% CI 1.43-5.38; p=0.003), and central venous catheter use (OR 3.39, 95% CI 1.65-6.98; p=0.001). Gram-negative isolates predominated (72.1%), led by Klebsiella pneumoniae (30.9%) and Acinetobacter baumannii (14.7%). Late-onset sepsis was significantly more likely than early-onset sepsis to yield Gram-negative pathogens (85.0% vs 53.6%; OR 4.91, 95% CI 1.57-15.39; p=0.006). Overall multidrug resistance was 60.3%. Among Gramnegative isolates, sensitivity was highest to colistin (98.0%) and meropenem (63.3%) but poor for ceftazidime (20.4%), gentamicin (34.7%), and amikacin (38.8%). Gram-positive isolates retained high sensitivity to vancomycin (94.7%) and linezolid (100%).
Conclusion
Bloodstream infection in septicemic neonates at tertiary-care level is dominated by multidrugresistant Gram-negative bacteria, particularly K. pneumoniae and A. baumannii. Unit-specific surveillance and early revision of empirical antibiotic policy are necessary to improve initial antimicrobial coverage and stewardship.
Zitieren
APA
Kumar, G., Anand, A. K., Kumar, S., & Priyadarshi, A. (2026). Spectrum and Antibiotic Sensitivity Pattern of Bloodstream Bacterial Isolates from Septicemic Neonates in a Tertiary Care Centre. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.109
Vancouver
Kumar G, Anand AK, Kumar S, Priyadarshi A. Spectrum and Antibiotic Sensitivity Pattern of Bloodstream Bacterial Isolates from Septicemic Neonates in a Tertiary Care Centre. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.109
BibTeX
@article{Kumar2026,
author = {Kumar, Ganesh and Anand, Ankush Kumar and Kumar, Satish and Priyadarshi, Ankur},
title = {Spectrum and Antibiotic Sensitivity Pattern of Bloodstream Bacterial Isolates from Septicemic Neonates in a Tertiary Care Centre},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {04},
doi = {10.25258/ijcpr.18.4.109}
}
EUVIMED